Advances in Anti-inflammatory Drug Development
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (20 October 2024) | Viewed by 2592
Special Issue Editor
Interests: inflammation; NLRP3 inflammasome; anti-inflammatory; anti-cancer drug development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammation is a complex set of physiological and pathological processes that can arise in any tissue in response to infectious agents and sterile disease-relevant stimuli. An abundance of new evidence demonstrates that aberrant and chronic inflammation promotes the development of a variety of diseases such as COVID-19, metabolic disorder, cancer, neurodegeneration, cardiovascular disease, and inflammatory bowel disease. Increasing evidence shows that inflammation is an imperative therapeutic target in many diseases. However, most current therapies have unmet medical needs, and better therapeutics targeting specific signaling pathways in the inflammatory response are urgently needed. This Special Issue, “Advances in Anti-inflammatory Drug Development”, welcomes original research and review articles in the field, with a focus on, but not limited to, anti-inflammatory small molecules or macromolecules produced by plants, microorganisms, animals, or chemical synthesis. Studies on inflammatory responses with a molecular and mechanistic basis, pathologies as a result of aberrant inflammation, and any interesting inflammation-related studies are also welcome.
Prof. Dr. Kuo-Feng Hua
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammation
- inflammatory disease
- infectious disease
- anti-inflammatory drugs
- innate immunity
- cytokines
- inflammasomes
- sterile inflammation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
